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Abstract 30 
 31 
Membrane proteins are frequently modulated by specific protein-lipid interactions. The 32 
activation of human inward rectifying potassium (hKir) channels by phosphoinositides (PI) 33 
has been well characterised. Here, we apply a coarse-grained molecular dynamics free-34 
energy perturbation (CG-FEP) protocol to capture the energetics of binding of PI lipids to 35 
hKir channels. By using either a single- or multi-step approach, we establish a consistent 36 
value for the binding of PIP2 to hKir channels, relative to the binding of the bulk 37 
phosphatidylcholine phospholipid. Furthermore, by perturbing amino acid side chains on 38 
hKir6.2, we show that the neonatal diabetes mutation E179K increases PIP2 affinity, while 39 
the congenital hyperinsulinism mutation K67N results in a reduced affinity. We show good 40 
agreement with electrophysiological data where E179K exhibits a reduction in neomycin 41 
sensitivity, implying that PIP2 binds more tightly E179K channels. This illustrates the 42 
application of CG-FEP to compare affinities between lipid species, and for annotating amino 43 
acid residues. 44 
 45 
46 
Introduction 47 
 48 
Ion channels are integral membrane proteins that mediate ionic flux across the plasma 49 
membrane. This process can be regulated by the binding of factors such as soluble ligands 50 
or phospholipids to the channel.  In particular, lipid binding has been shown to affect many 51 
types of ion channel, regulating both their oligomeric state and their activation1. Impairment 52 
of these processes can lead to a range of human and animal diseases. One well-studied 53 
class of ion channels are the mammalian inward rectifying potassium (Kir) channels. In the 54 
case of Kir6.2, the pore component of the ATP-sensitive potassium (KATP) channel complex, 55 
mutations may result in either a loss, or gain, of channel function, resulting in congenital 56 
hyperinsulinism (CHI) and neonatal diabetes (NDM), respectively7. 57 
 58 
Kir channels are activated by phosphoinositides, in particular phosphatidylinositol-4,5-59 
bisphosphate (PIP2)8. Different Kir channels exhibit variable affinities and levels of channel 60 
activation to different phosphoinositides9–11. The PIP2 binding site on Kir channels has been 61 
well defined in several crystal structures, such as chicken Kir2.2 [PDB entry: 3SPI]12 and 62 
mouse Kir3.2 [PDB entry: 3SYA]13. Meanwhile, recent advances in cryo-electron microscopy 63 
(cryo-EM) have enabled several high-resolution structures of the pancreatic KATP channel 64 
complex (Supplementary Table 1), which comprises a central tetrameric pore formed of 65 
Kir6.2 subunits, surrounded by four regulatory sulfonylurea receptor 1 (SUR1) subunits14. 66 
This octameric complex couples pancreatic beta-cell energy status to insulin secretion15. 67 
Mutations in the Kir6.2 subunit that are located near the PIP2 binding site are associated with 68 
NDM (e.g. E179K/A) and CHI (e.g. K67N)16–18. A previous study has shown that the K67N 69 
mutation does not alter channel surface expression but has reduced channel activation 70 
when cell metabolism was inhibited18. The mechanism of how E179K/A and K67N mutations 71 
affect channel activity is currently unclear. 72 
 73 
Kir channels form an attractive target for applying a computational approach to compare 74 
binding affinity between phosphoinositides and also assess the impact of mutations on 75 
binding. Coarse-grained (CG) molecular dynamics (MD) simulations have previously been 76 
used to identify lipid-binding sites on ion channels3–5, as well as predicting the affinity of 77 
interactions6. 78 
 79 
For many years, the application of atomistic free energy perturbation (FEP) methods have 80 
been successfully applied to determine small molecule, lipid, and drug binding affinities19 as 81 
well as to study the impact of amino acid side chain mutations20,21. Our recent study showed 82 
how the method could be extended to a CG protocol (CG-FEP) to assess relative protein-83 
lipid binding free energies. This approach was in strong agreement with other free energy 84 
calculation methods such as potential of mean force calculation (PMF) and well-tempered 85 
metadynamics (WTMetaD)6.  86 
 87 
In this study, we use CG-FEP6 to compare the relative binding free energies between 88 
different phospholipids and the human Kir6.2 channel, capturing the full thermodynamic 89 
cycle for the transition of PIP2 to PC, either directly or via intermediates phosphatidylinositol-90 
4-phosphate (PI4P) and phosphatidylinositol (PI), and thereby reporting on the affinity of 91 
each interaction. We extend the methodology to investigate the functional effect of lipid-92 
associated neonatal diabetes mutations (E179K/A) and a congenital hyperinsulinism (CHI) 93 
mutation (K67N) in hKir6.222,23. Based on the predicted binding site for PIP2, we calculate 94 
that these residues interact with PIP2 in the membrane. This therefore provides a 95 
biochemical and structural explanation for the different clinical phenotypes.  96 
 97 
We couple these analyses with electrophysiology, to assess both the affinity for, and 98 
channel activation by, PIP2. We also extend the computational methodology to assess the 99 
binding free energy differences between a range of hKir channels (hKir1.1, hKir2.2, and 100 
hKir3.2) and other inositide lipid species such as phosphatidylinositol-4-phosphate (PI4P) 101 
and phosphatidylinositol (PI). Together, our application of the CG-FEP describes the affinity 102 
of membrane proteins with a range of different lipids, as well as examining how biologically 103 
important mutations affect these interactions. 104 
 105 
  106 
 107 
Results 108 
 109 
PIP2 binding conformation to the hKir6.2 channel 110 
 111 
The initial position of the PIP2 molecule was obtained from the chicken Kir2.2 channel:diC8-112 
PIP2 complex12. After structural alignment of hKir6.2 with chicken Kir2.2, one of the bound 113 
diC8-PIP2 molecules was extracted, converted to CG and the resultant hKir6.2-PIP2 complex 114 
was built into a PC membrane and simulated for 1 μs (n = 5) using CG lipid self-115 
assembly3,4,24. We defined residues that were within a 6 Å radius of the whole PIP2 molecule 116 
for >75 % of simulation time as proximal residues (Fig. 1a). We found that PIP2 binds in the 117 
vicinity of both the N- and C-termini of the hKir6.2 channel, including 67KWP69, on the N-118 
terminus, and the residues between 170 and 179 on the C-terminus. These regions contain 119 
a number of basic residues, which allows them to interact with the negatively charged 120 
phosphate groups on the inositol ring of the PIP2 headgroup. E179 is the only negatively 121 
charged amino acid to be within this cut-off from the lipid.  122 
 123 
We assessed the stability of PIP2 in its binding site using Root Mean Square Deviation 124 
(RMSD) analysis over the 1 μs simulations (Fig. 1b). The data show that the position of the 125 
PIP2 diverges very little in 1 µs (RMSD = ca. 0.8 Å). This was corroborated by analysing the 126 
distance between the PIP2 molecule and two amino acids near the PIP2 binding site, K67 127 
and E179 (Figs. 1c and 1d). We found that the minimum distance between K67 and E179 128 
and the PIP2 head group are approximately 5 Å respectively (Supplementary Fig. 1). 129 
Therefore, we hypothesise that mutations to these residues may affect the binding free 130 
energy of PIP2 to the channel.   131 
 132 
 133 
Step-wise perturbation of the PIP molecule bound to the hKir6.2 channel 134 
 135 
We next assessed the contribution that each of the different PIP headgroup moieties (i.e. 136 
each phosphate group and the inositol ring) make to the free energy of binding to the closed 137 
hKir6.2 tetramer using CG-FEP. For this, we iteratively perturbed single beads to transform 138 
from one phospholipid (such as PIP2) into another (such as PC). This enabled us to 139 
calculate the binding free energy difference (∆∆G) of the two different phospholipids to 140 
hKir6.2, embedded in a PC bilayer (Fig. 2a). For simplicity, all of our lipids have both 141 
palmitoyl and oleoyl alkyl chains. The energies were computed using Multistate Bennett 142 
Acceptance Ratio (MBAR)25, with convergence seen within ca. 200 ns per window 143 
(Supplementary Figs. 2a-b, 3a-b, 4-b and 5a-b). To prevent the molecule from leaving its 144 
binding site, we applied a flat-bottom distance restraint between the protein and lipid using 145 
Plumed26,27 (Supplementary Figs. 2a-c and 3a-c). This was mostly applicable for the 146 
calculations in which the lipid was transformed to PC. In the cases where the lipids remain 147 
bound at the binding site, applying a flat-bottom restraint makes no difference to the binding 148 
free energy and its convergence. (Supplementary Figs. 4c and 5c). This procedure also 149 
reduced the errors between simulation replicas. The infrequency with which the lipid 150 
experiences the restraint suggests that it has negligible effect on the binding energies 151 
(Supplementary Figs. 2d and 3d). 152 
 153 
Transformation from PIP2 to PI4P showed a very small relative free energy change (Fig. 2b 154 
and Supplementary Table 2). This suggested that a phosphate group at either the 5’ position 155 
does not make a considerable contribution to PIP2 binding (Fig. 2b and Supplementary 156 
Table 2). However, we observed large free energy changes when the last phosphate group 157 
at the 4’ position and the inositol ring were perturbed (Fig. 2b and Supplementary Table 2). 158 
Summation of each individual moiety from PIP2 to PC gives a binding free energy of 30 ± 1 159 
kJ/mol, which is remarkably similar to the 33 ± 3 kJ/mol we obtain for direct perturbation of 160 
PIP2 to PC (Fig. 2c, Supplementary Table 2, and Supplementary Fig. 6). This suggests that 161 
the approach we use is valid for both single- and multi-step free energy calculations.  162 
 163 
A previous study demonstrated that crosstalk between different anionic lipids can affect the 164 
affinities of each lipid for the Kir2.2 channel28. Here, we show that the presence of 10% 165 
anionic lipid (POPS) in the lower leaflet of the bilayer does not affect the overall ∆∆G for 166 
PIP2 binding to Kir6.2 (Supplementary Figure 7).  167 
 168 
Previous electrophysiological and crystallographic studies have commonly used the soluble 169 
eight-carbon atom phosphatidyl inositol, diC8-PIP2, to study channel activation12,13,17.  170 
Therefore, we investigated the effect of the length of the acyl chain on PIP2 binding affinity. 171 
We found that truncation of the acyl chain from either 4 or 5 particles (i.e. palmitoyl and 172 
oleoyl) to 2 particles (equivalent to 8 carbon atoms) had no effect on PIP2 affinity (Fig. 2d). 173 
This suggests that PIP2-diC8 is indeed an effective substitute for investigating the impact of 174 
PIP2 binding in electrophysiological and structural studies. 175 
 176 
 177 
Relative binding free energy calculations for PIP2 interactions with both wild-type and mutant 178 
hKir6.2 179 
 180 
Based on the closed state model of Kir6.2 [PDB: 6BAA], we generated three structural 181 
models of hKir6.2 with disease-associated mutations; K67N which causes CHI, and E179A 182 
and E179K which cause neonatal diabetes22,23. As these residues are in close proximity to 183 
the PIP2 binding site (Fig. 1e), we hypothesised that mutations to these residues would 184 
modulate PIP2 affinity and thereby affect basal channel activity (i.e., the channel open 185 
probability, Po). An increase in PIP2 binding affinity should correlate with an increase in 186 
channel activation (Po) and thus also a reduced inhibition by ATP.  187 
 188 
We next performed calculations in which the mutated hKir6.2 residue was perturbed in the 189 
presence and absence of PIP2 (Fig. 3a). This allows us to calculate the relative changes in 190 
the PIP2 binding free energy between the wild-type and mutant channels. For the highest 191 
energy residue substitution (E179K), we observed convergence of the free energy 192 
calculations within 50 ns per window (Supplementary Fig. 8). The data show an increase in 193 
PIP2 binding energy, and hence an increased affinity, with the E179K transformation. We 194 
also observed an increase in binding free energy with the E179A mutation (Fig. 3b and 195 
Supplementary Table 4). Conversely, we see a reduction in PIP2 binding affinity with the 196 
K67N transformation (Fig. 3b and Supplementary Table 4). This quantitatively confirms that 197 
both the E179K and E179A mutations increase PIP2 channel affinity, whereas the K67N 198 
mutation decreases channel affinity. This agrees with the patient phenotypes: E179K causes 199 
NDM, i.e. an increase in channel activity, whereas K67N causes CHI, a reduction in channel 200 
activity.  201 
 202 
As a control, we investigated an NDM mutation, C166S, which is distant from the PIP2 203 
binding site.  We expected that this mutation would have no impact on the PIP2 binding 204 
affinity, despite having an influence on the channel opening probability29. When perturbing 205 
the site using single residue FEP, we see effectively no change in PIP2 affinity of the 206 
channel, and therefore, unlike the E179A/K mutations, the C166S mutant does not appear to 207 
increase channel opening probability by increasing PIP2 affinity (Fig. 3c and Supplementary 208 
Table 2), but by a different mechanism.   209 
 210 
Experimental assessment of PIP2 binding to NDM mutant channels 211 
 212 
We next assessed the neomycin sensitivity of the E179K mutant both in the presence and 213 
the absence of SUR1 to ascertain if the mutation increases both channel PIP2 affinity and 214 
channel activation (Fig. 4a-b). To enable expression of Kir6.2 without SUR1 we used a C-215 
terminally truncated construct, Kir6.2∆C36, which has been previously shown to express 216 
and traffic to the plasma membrane without SUR130. Neomycin, a polycationic antibiotic, has 217 
previously been used as a tool to study Kir ion channel activation by PIP2 17. While it does 218 
not bind to Kir channels directly, it acts by reversibly binding to PIP2, screening the charges 219 
and preventing binding31. A decrease in neomycin sensitivity (i.e. an increase in neomycin 220 
IC50) would indicate an increase in PIP2 dependent channel activation (i.e. PIP2 has a 221 
greater affinity for the Kir channel upon mutation). Another indication of an increase in 222 
channel activation by PIP2 is a slower rate of channel rundown and an increase in channel 223 
open probability32. We used these criteria to assess the effect of the SUR1 subunit on 224 
channel sensitivity to PIP2. 225 
 226 
We observed a 20-fold and a 50-fold increase in the IC50 value for neomycin block with the 227 
E179K mutation, both in the presence and absence of SUR1 respectively  (Kir6.2-SUR1: 228 
IC50 = 81 µM, h=0.96, Kir6.2-E179K-SUR1: IC50 = 1.7 mM, h= 1.13, Kir6.2∆C, IC50 = 55 μM, 229 
h= 0.61 and Kir6.2∆C-E179K, IC50 = 3.3 mM, h = 1.6) This suggests an increase in the PIP2 230 
sensitivity of the E179K variant channel both in the presence and in the absence of the 231 
SUR1 subunit, in agreement with our free energy calculations. Interestingly, in the presence 232 
of SUR1, channels with the Kir6.2-E179K mutation failed to fully close even in the presence 233 
of a very high neomycin concentration (0.1 M) (Fig. 4b). This suggests that the E179K 234 
mutation, in the presence of SUR1, may interfere with the channel gating mechanism 235 
independently of PIP2 action. 236 
 237 
Assessment of the PIP2 activity dependency on SUR1 subunit 238 
 239 
Next, we experimentally assessed the importance of the SUR1 subunit for PIP2 binding 240 
affinity and activation. Previous studies suggested that the presence of SUR1 enhances the 241 
Po of Kir6.2∆C33,34. However, the contribution of PIP2 to this modulation and the relationship 242 
between SUR1 and PIP2 sensitivity remains unclear. To address this issue, we calculated 243 
the relative binding free energy of hKir6.2 and PIP2 in both the presence and absence of the 244 
SUR1 subunit. Here, we show that addition of SUR1 only marginally increases the PIP2 245 
binding free energy (Fig. 4c). Therefore, this result suggests that SUR1 has only a minor 246 
contribution to PIP2 affinity even though the SUR1 is only approximately 8 Å away from PIP2 247 
headgroup. 248 
 249 
To confirm that SUR1 has no effect on channel activation, we cloned and expressed Kir6.2 250 
with SUR1 and Kir6.2∆C in Xenopus oocytes and assessed the neomycin sensitivity of the 251 
channel. We found there was no significant difference in channel neomycin sensitivity in the 252 
presence and absence of SUR1 (Kir6.2/SUR1: IC50 = 81 µM, h = 0.96, Kir6.2∆C, IC50 = 54 253 
μM, h = 0.61) (Fig. 4d). This is in qualitative agreement with lack of a change in the free 254 
energy of PIP2 binding calculated from our FEP calculations. 255 
 256 
PIP2 binding affinity to other human inward rectifying potassium (hKir) channels 257 
 258 
We next assessed the binding of PIP2 across other hKir channels by calculating the binding 259 
free energy of PIP2 perturbation to PC for the human Kir1.1, Kir2.2 and Kir3.2 (hKir1.1, 260 
hKir2.2 and hKir3.2) channels using the thermodynamic cycle described in Fig. 2a. The 261 
electrophysiological behaviour of these channels on PIP2 binding is well characterised9. We 262 
therefore perturbed PIP2 to PC, the dominant phospholipid species in the eukaryotic plasma 263 
membrane. Note that a potential of mean force (PMF) calculation shows the binding energy 264 
of PC to hKir6.2 is 0 ± 2 kJ/mol (Supplementary Fig. 9).  Due to the absence of human 265 
Kir1.1 and human Kir2.2 structures in the PIP2 bound conformation, we generated hKir 266 
molecular models of both, as described in the Materials and Methods. The PIP2 binding sites 267 
and interacting residues on these proteins are all highly conserved (Fig. 5a-c, 268 
Supplementary Fig. 10).   269 
 270 
Our data reveal that the binding free energy of PIP2 to hKir1.1, hKir2.2 and hKir3.2 channels 271 
is higher than that to hKir6.2 channels (Fig. 6a and Supplementary Table 5). In our study, 272 
the PIP2 binding free energy value described here for hKir2.2 is similar to that previously 273 
recorded for the chicken Kir2.2 channel, which was reported as ca. -46 kJ/mol both using 274 
FEP and PMF6,35. The higher affinity of hKir3.2 was rather unexpected, as hKir3.2 has an 275 
equivalent glutamate in the same position at E179 on hKir6.2 (denoted as E201) (Fig. 5d). 276 
However, the minimum distance between the PIP2 headgroup and hKir3.2-E201 (ca. = 8.5 277 
Å) is greater than that of than that of hKir6.2-E179 (ca. = 5 Å) in our molecular models.  278 
 279 
In order to account for the free energy difference between PIP2 and PC to all hKir channels, 280 
we examined the contribution of the individual phosphate and inositol groups of PIP2 in the 281 
binding to each of the channels, as described above (Fig. 2a). First, we show that the 282 
binding energy contributed by the 5’ phosphate is higher in hKir1.1 than the other three 283 
channels (PIP2>PI4P; Fig. 6b and Supplementary Table 6). In addition, we observed that 4’ 284 
phosphate and the inositol ring contribution is stronger in all other channels relative to 285 
hKir6.2 (PI4P>PI; Fig. 6b and Supplementary Table 6). Overall, this accounts for most of the 286 
energy differences as we perturbed PIP2 to PC in hKir1.1, hKir2.2 and hKir3.2. For both 287 
single- and multi-step approaches, hKir6.2 exhibited the lowest binding free energy for PIP2. 288 
 289 
  290 
Discussion 291 
 292 
Here we build on our recent application of the CG-FEP approach for comparing the binding 293 
free energy between two lipid species to a given site on a membrane protein6. We show that 294 
this approach enables us to complete a thermodynamic cycle where the sum of the 295 
individual perturbation steps (i.e. PIP2>PI4P>PI>PC) is equivalent to the single-step 296 
transformation from PIP2 to PC (Supplementary Fig. 6). The results of our application of the 297 
free-energy calculations are within the range of values that are commonly observed for PIP2 298 
interactions with membrane proteins6,35–37. One of our concerns is the ability of the CG 299 
forcefield to distinguish between similar inositol lipids in the free energy calculations. This 300 
application of CG-FEP has demonstrated that the method can show differences between 301 
PIP2, PI4P, PI and PC at the accuracy of at least 5 kJ/mol (~1.5 kBT). This complements the 302 
previous free energy calculations, which show that the CG forcefield is able to distinguish 303 
between PIP2 and PIP337.  Overall, this illustrates the robustness of the application and 304 
demonstrates its power as a relatively cheap and effective in silico approach for comparing 305 
lipid-binding free energies to a membrane protein of interest. Nevertheless, although there is 306 
good agreement between the single- and multi-step approaches we cannot exclude the 307 
possibility that the individual particle contributions may be either over- or under-estimated 308 
due to the CG approach. 309 
 310 
In addition, we demonstrate that amino acid mutations can also be investigated using CG-311 
FEP, thus allowing us to probe the effect of a given amino acid’s substitution on lipid binding. 312 
This is an extension to the traditional atomistic FEP mutation approach21, which enables 313 
convergence to be achieved more quickly and easily21. It also allows binding to be much 314 
more easily measured than in vitro lipid binding studies. Thus, the application of CG-FEP is 315 
potentially a valuable tool for the relatively high-throughput analysis of multiple disease-316 
causing mutations that are related to lipid binding.  317 
 318 
To test the capabilities of these methodologies, we applied them to the KATP channel 319 
(Kir6.2/SUR1), a biologically important potassium channel that is implicated in insulin 320 
secretion. We used a combination of the above methods to demonstrate that clinically 321 
identified mutations in the Kir6.2 subunit (causing NDM and CHI) affect the affinity of the 322 
channel for different PIP lipids. In addition, we demonstrated that the neonatal diabetes 323 
mutations - E179K and E179A - which lie near the PIP2 binding site result in channel gain of 324 
function by enhancing PIP2 binding (and Po). We present both computational and 325 
electrophysiological data which are in good agreement, thereby demonstrating that this 326 
application of an existing method provides a potentially powerful method for the scanning 327 
and annotating of how disease-associated mutations modulate lipid binding to channels. 328 
 329 
  330 
Methods 331 
 332 
Molecular modelling 333 
 334 
Modeller9v1638 was used to add the missing loops and amino acid residues to the cryo-EM 335 
structure of the Kir6.2 channel [PDB entry: 6BAA]39 and to generate a human Kir6.2 model 336 
based on residues 32-352. In both the cryo-EM structure and our model there are 32 amino 337 
acids missing at the N-terminus and 39 at the C-terminus. Modeller9v16 was also used to 338 
generate a model of the human KATP channel octamer (hKir6.2 tetramer + four SUR1 [PDB 339 
entry: 6BAA]) and the models of the hKir6.2 mutant channels. Each model was compared to 340 
its initial template structure to ensure that the modelling had not demonstrably altered the 341 
original secondary structure or the rotation of the amino acid sidechains (overall RMSD of all 342 
protein atoms < 1.0 Å). Models of the other hKir channels were generated using Swiss-343 
Model40, with human Kir1.1 and Kir2.2 based on 3SPH and human Kir3.2 based on 3SYA. 344 
The chicken Kir2.2 structure with bound diC8-PIP2 [PDB entry: 3SPI]12 was used to dock 345 
PIP2 to hKir6.2.  346 
 347 
Coarse-grained (CG) Simulations 348 
 349 
All protein structures were converted to their CG representation and embedded in a PC (1-350 
palmitoyl-e-oleoyl-sn-glycero-3-phosphocholine) bilayer using the self-assembly 351 
MemProtMD protocol24,41 and the MARTINI v2 biomolecular forcefield4. This approach 352 
orients the structure of the transmembrane protein parallel to the z-axis using 353 
MEMEMBED42. The protein is then placed in a periodic box at minimum distance of 30 Å 354 
from the edge of the box in both x and y directions, and with a z dimension of 80 Å. The 355 
structure is then converted to a CG representation with martinize.py with an application of an 356 
elastic network with a force constant of 1,000 kJ/mol/nm2 between backbone beads within 357 
0.5-0.9 nm to maintain their secondary and tertiary structure. The PC lipid is then added to 358 
the periodic box, allowing them to assemble freely around the protein. The z-dimension of 359 
the box is then extended so that the minimum distance between the protein and the face of 360 
the box is 30 Å apart, and then flooded with the coarse-grain water particles, Na+ and Cl- 361 
ions to a final concentration of 0.15 M to neutralize the system. The total number of the 362 
molecules in the setup is described in the supplementary table 8. A temperature of 323 K 363 
was maintained with V-rescale temperature coupling43, while 1 atm pressure was controlled 364 
using semi-isotropic Parrinello-Rahman pressure coupling44. Systems were energy 365 
minimised using the steepest descents algorithm and equilibrated for 5 ns with 1,000 366 
kJ/mol/nm2 position restraints on backbone beads, prior to 1 µs production. All simulations, 367 
root mean square deviation (RMSD) calculations and distance analyses were carried out 368 
using GROMACS v201845 and all structural alignments and docking were carried out using 369 
PyMOL.46  370 
 371 
Free energy perturbation (FEP) calculation of PIP lipids 372 
 373 
The hKir6.2 tetramer with one bound PIP2, obtained after equilibration, was used as the 374 
initial co-ordinates for the majority of the FEP calculations. Here, we calculate a relative 375 
binding free energy (∆∆G) by converting from one lipid type (such as PIP2) to a series of 376 
other phospholipids (such as PIP2, PI4P, PI and PC) along a reaction coordinate in a 377 
chemical space denoted λ (Fig. 2a). As is standard for FEP calculations, separate 378 
transformations were performed with either the lipid bound to the channel or in bulk 379 
membrane.  380 
 381 
We applied FEP to hKir6.2, hKir3.2, hKir2.2 and hKir1.1 and the following pairs of inositol 382 
lipids: (PIP2 and PI4P), (PI4P and PI), (PI and PC) and (PIP2 and PC). This allows us to 383 
create a thermodynamic cycle for the different lipids of interest (Supplementary Fig. 6). For 384 
these, specific phosphate and inositol sugar particles were transformed into a dummy 385 
particle with no interaction properties, in a stepwise process as described in Fig. 2b. 386 
Coulombic (charge interactions) and Lennard-Jones (van der Waals interactions) were 387 
turned off separately, with a soft-core parameter used for the Lennard-Jones interactions. 388 
The coulombic interactions were perturbed linearly (λ = 0, 0.1, 0.2 … 0.9, 1.0) in the first 10 389 
simulation windows, with the van der Waals interactions perturbed linearly (λ = 0, 0.1, 0.2 390 
…… 0.9, 1.0)  in the last 10 simulation windows with the soft-core parameters of α = 0.5 and 391 
σ = 0.3. Each simulation window was energy minimised and equilibrated as described 392 
above, before three production runs were carried out for 250 ns with randomised initial 393 
velocities, using a leap-frog stochastic dynamics integrator. A flat-bottom distance restraint 394 
between the PO4 phosphate group and protein backbone beads at 6 Å radii from the PIP 395 
molecule was applied using Plumed (1000 kJ/mol/nm2, 8 Å cut-off)27. This prevents the 396 
bound lipid from drifting away from its binding pocket and increases the accuracy of the 397 
calculation (Supplementary Fig. 1b,1c). The free energy pathways were constructed using 398 
the alchemical-analysis software package47, where the energies are calculated based on the 399 
300 ns of the data for a good convergence6. Thus, a total of 642.6 μs simulations were 400 
performed for the FEP calculations performed in this study. Analyses was run using the 401 
Multistate Bennett Acceptance Ratio (MBAR)25. All values are reported are reported as 402 
mean ± SEM. All simulations were carried out using GROMACS v201845. 403 
 404 
 405 
Free energy perturbation (FEP) between amino acid residues 406 
 407 
As before, the PIP2-bound equilibrated hKir6.2 system was used as the initial co-ordinates 408 
for the FEP calculations. When assessing the influence of ND or CHI mutations, we 409 
calculated changes in the relative binding free energy (∆∆G) by alchemically transforming 410 
the wild-type amino acid residue to its mutant counterpart. This was performed using a 411 
change in chemical space denoted as λ, and applying the previously described protocol. The 412 
series of transformations carried out are shown in Supplementary Table 7. Additional 413 
simulations were run by performing the same perturbation of the protein in a bulk POPC 414 
membrane in the absence of PIP2. The ∆∆G terms were then calculated as described in Fig. 415 
3b. 416 
 417 
Potential of Mean Force Calculation (PMF) 418 
 419 
PMF calculations were set up similarly to that described previously6. The protein was built in 420 
the POPC bilayer, and a single POPC lipid was pulled from the binding site using steered-421 
MD, where the collective variables (CV) are the distance between the lipid headgroup and 422 
the centre of mass of the protein. The initial position for POPC was modified from an initial 423 
PIP2 co-ordinate. The simulations were calculated along the CV at 0.2 Å interval for optimal 424 
histogram overlap, with a 1000 kJ/mol/nm2 umbrella potential applied to restrain the position 425 
of the lipid along the CV. Positional restraints of 100 kJ/mol/nm2 were applied to the protein 426 
backbone to prevent rotation of the protein in the bilayer. For each window, the simulations 427 
were run for 500 ns, which was sufficient to see convergence. Thus, this adds up to a total of 428 
20 μs for the PMF calculations. The 1D energy profile was generated using weighted 429 
histogram analysis method (WHAM) using the gmx wham tool (200 rounds Bayesian 430 
Bootstrap) 48.  431 
 432 
Molecular biology 433 
Human Kir6.2 (Genbank NM000525) and human SUR1 (Genbank NM_000352.5) were 434 
cloned into the pBF vector. Site-directed mutagenesis was performed using QuickChange 435 
XL (Stratagene), followed by synthesis of capped mRNA using mMESSAGE (Invitrogen). All 436 
constructs were validated by restriction digest and DNA sequencing (MRC I PPU, School of 437 
Life Science, University of Dundee, Scotland). Xenopus laevis oocytes were prepared as 438 
previously reported 49. The oocytes were co-injected with ∼4 ng of SUR1 mRNA and ∼0.8 439 
ng wild-type or mutant Kir6.2 mRNA. In some experiments, oocytes were injected with wild-440 
type or mutant Kir6.2 possessing a C-terminal 36 amino acid truncation (Kir6.2∆C) mRNA, 441 
which allows surface membrane expression33. Oocytes were incubated in Barth's solution 442 
and studied 1–4 days after injection. 443 
 444 
Electrophysiology 445 
Inside-out patch-clamp recordings were performed using an EPC7 amplifier (List Electronik) 446 
at a constant holding potential of −60 mV. The pipette solution contained 140 mM KCl, 1.2 447 
mM MgCl2, 2.6 mM CaCl2, 10 mM HEPES (pH 7.4 with KOH). For experiments with 448 
neomycin, the Mg-free intracellular solution contained 107 mM KCl, 10 mM HEPES and 10 449 
mM EDTA (pH 7.2 with KOH). To account for possible rundown, the control current (IC) was 450 
taken as the mean of the current in control solution before and after neomycin application. 451 
Concentration–response curves were fitted with a modified Hill equation (1):  452 
 453 
ூ
ூ೎ = 	
௔ା(ଵି௔)
ଵା( ሾ೉ሿ಺಴ఱబ)
೓   (1) 454 
 455 
where [X] is the concentration of the test substance, IC50 is the concentration at which 456 
inhibition is half maximal, h is the slope factor (Hill coefficient) and a represents the fraction 457 
of unblocked current at saturating neomycin. Single-channel currents were recorded at -60 458 
mV, filtered at 5 kHz, sampled at 20–50 kHz, and analysed using a combination of Clampfit 459 
(Axon Instruments) and GraphPad Prism 8. Data are given as mean ± SEM. 460 
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 617 
  618 
Figures 619 
 620 
Fig. 1  621 
 622 
A PIP2 binding site on hKir6.2 623 
 624 
a PIP2 contact analysis showing the fraction of time that residues are in 6 Å proximity to 625 
the PIP2 molecule (contact probability). Only residues with a >75% contact probability 626 
are shown. Data from 5 repeats of 1 µs simulations. 627 
b Root mean square deviation (RMSD) analysis of the PIP2 molecule headgroup when 628 
bound to the hKir6.2 tetramer. The different colours indicate the individual repeats of the 629 
simulations (n=5). The darker lines show the running average for each simulation. 630 
c Calculated distance between K67 and the PIP2 headgroup during a 1 µs simulation. The 631 
different colours indicate the individual repeats of the simulation. The darker line shows a 632 
running average. A dashed black line denotes the distance cutoff used to denote a 633 
contact in panel (a). 634 
d As in panel (c) but for E179 and the PIP2 headgroup.  635 
e PIP2 binding site on the hKir6.2 tetramer (green) showing PIP2 (grey with CPK colours), 636 
E179 (magenta) and K67 (blue). 637 
 638 
  639 
Fig. 2  640 
 641 
The free energy calculation of an individual phosphate group and fatty acid chains on a 642 
hKir6.2 tetramer. 643 
 644 
a Thermodynamic cycle used for the relative binding free energy calculations. The 645 
perturbation of the PIP2 headgroup (purple) was calculated in both the channel bound 646 
state (∆G2) and free in the PC membrane (grey rectangle (∆G1)). ∆G3 and ∆G4 can be 647 
calculated using such methods as PMF calculations (Figure 2 - Figure Supplement 6) 648 
b Coarse-grain to atomistic mapping of the phosphoniositides (PIP2, PI4P, PI and PC) 649 
c Change in binding free energy (∆∆G) when individual phosphate groups are perturbed 650 
(i.e. from PIP2 to PI4P, from PI4P to PI and from PI to PC (values in black). The sum of 651 
these free energy changes (i.e. from PIP2 to PC) is given in red. Values are rounded to 652 
the nearest whole number. 653 
d Change in binding free energy when PIP2 is perturbed to PC. Values are rounded to the 654 
nearest whole number. 655 
e Change in binding free energy when PIP2 is perturbed to PIP2-diC8. Values are rounded 656 
to the nearest whole number 657 
 658 
  659 
Fig. 3  660 
 661 
Free energy calculations using disease associated Kir6.2 mutations. 662 
 663 
a Schematic diagram showing the free energy calculation. An amino acid residue (blue 664 
sphere) is transformed into another residue (yellow sphere) between two states (PIP2 665 
bound and free). 666 
b The energetic cost of making the residue mutation based on the schematic diagram (a). 667 
 668 
  669 
Fig. 4  670 
 671 
An effect of SUR1 subunit and NDM mutation on PIP2 affinity and activation. 672 
 673 
a Mean relationship between the neomycin concentration and the KATP current (I), 674 
expressed relative to the current in the absence of neomycin (I0) for Kir6.2∆C (open 675 
squares, n=5) or hKir6.2∆C-E179K channels (filled squares, n=5).   676 
b Mean relationship between the neomycin concentration and the KATP current (I) 677 
expressed relative to the current in the absence of neomycin (I0), for Kir6.2/SUR1 (open 678 
squares, n=5) or hKir6.2-E179K/SUR1 channels (filled squares, n=5).   679 
c (Left) Binding free energy between PIP2 and Kir6.2 ± SUR1. Values are rounded to the 680 
nearest whole number. Error bars represent the SEM (n=3) (Right) The PIP2 (grey) 681 
binding sites between hKir6.2 and SUR1. 682 
d Mean relationship between the neomycin concentration and the KATP current (I), 683 
expressed relative to the current in the absence of neomycin (I0), for Kir6.2 co-expressed 684 
with SUR1 (open squares, n=5) or hKir6.2∆C expressed without SUR1 (filled squares, 685 
n=5).  686 
 687 
  688 
Fig. 5  689 
 690 
Free energy calculations for different hKir channels 691 
 692 
Models of a hKir1.1, b hKir2.2 and c hKir3.2 channels in the PIP2 bound conformations after 693 
1 μs of CG simulation and converted back to an atomistic description. Insets: Carbons of key 694 
PIP2 binding residues are highlighted in yellow, with PIP2 otherwise shown in CPK colours. 695 
d Sequence alignment between hKir1.1, hKir2.2, hKir3.2 and hKir6.2 channels on the region 696 
where the contacts are conserved between more than two channels. Highlighted in yellow 697 
are residues that contact PIP2 for more than 70% of the 1 μs simulations (n=5). Long 698 
cylinder represents an α-helix in the secondary structure and the line represents either 699 
disordered region or a kink within the α helix. Acid residues (Asp, Glu) are shown in red, 700 
basic residues (Lys, Arg) are shown in blue, Polar residues (Ser, Thr, Cys, Gln, Asn) are 701 
shown in green. Other residues are shown in black.  702 
 703 
  704 
Fig. 6  705 
 706 
Free energy calculations for different hKir channels 707 
 708 
a Binding free energy changes between different hKir channels as PIP2 is perturbed to PC. 709 
(n=3). 710 
b Binding free energy changes between PIP2 and hKir1.1, hKir2.2, hKir3.2 or hKir6.2 as 711 
each PIP2 phosphate group is sequentially perturbed: from PIP2 to PI4P, then to PI and 712 
finally to PC (black). The sum of the free energy change from PIP2 to PC is shown in red. 713 
Values are rounded to the nearest whole number. Error bars represent the SEM (n=3). 714 
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Protein-lipid interactions can mediate the function of membrane proteins. Here coarse-grained 1 
molecular dynamics free energy perturbation simulations yield binding free energies for 2 
phosphoinositide lipids to hKir channels and mutants, in agreement with electrophysiological 3 
measurements. 4 
